Immunosuppressive Agents: An Interview
In a recent Core Curriculum published in AJKD, Sam Kant, Andreas Kronbichler, and Duvuru Geetha explore different classes of immunosuppressive drugs, how to choose [...]
Articles by AJKDblog
Highlights from the October 2022 Issue
Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired their study, the basic [...]
Kidney Disease in the Hispanic Population
Sylvia E. Rosas @sylviaerosas Sylvia E. Rosas, MD, MSCE is a nephrologist and epidemiologist at the Joslin Diabetes Center and an Associate Professor of Medicine at Harvard [...]
Waitlist Eligibility and Disparities in Transplant Access
Adrian Whelan @AdrianWhelan6 Dr. Adrian Whelan is a Transplant Nephrologist at University of California, San Francisco. He completed the AJKD Editorial Internship during its [...]
Measuring the Success of Advanced Care Planning Implementation in Chronic Kidney Disease Clinics: The Importance of Organizational Readiness
Lachlan McMichael @lachlan_mcm Dr. Lachlan McMichael is a nephrologist & early career clinician-researcher. He is currently undertaking a Kidney Transplant Research [...]
Is Metformin Now in Our Armamentarium for Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Orhan Efe @OrhanEfe_ Dr. Orhan Efe is a Nephrologist at Massachusetts General Hospital in Boston, MA. Dr. Efe was an AJKD Editorial Intern from 2021-2022. He is passionate [...]
Highlights from the September 2022 Issue
Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired their study, the basic [...]
Preeclampsia is Not Only a Risk Factor for CKD but Also for Future AKI
Ana Cecilia Farfan Ruiz @AnaCeciliaFarf1 Dr. Ana Cecilia Farfan Ruiz was an AJKD Editorial Intern from 2021-2022. She is currently a renal transplant fellow at the Mayo [...]
Terlipressin, CONFIRM, and the Future of Hepatorenal Syndrome
Physiologic derangements leading to hepatorenal syndrome and effects of terlipressin. Figure 1 from Velez et al, AJKD © National Kidney Foundation. Hepatorenal [...]
High Sensitivity Troponin and N-terminal Pro-Brain Natriuretic Peptide in Kidney Disease: Personalized Medicine or Renalism?
Raphael Rosen @RaphyRosen Dr. Raphael Rosen was an AJKD Editorial Intern from 2021-2022. A recent graduate of nephrology fellowship at Columbia University, he is a [...]